"Urothelial bladder carcinoma" trang 1 - tải miễn phí từ tailieunhanh
Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: A case control study

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: A case control study
8    70    1
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014

Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
11    59    1
Young age increases the risk of lymphnode metastasis in patients with muscleinvasive bladder urothelial carcinoma

Young age increases the risk of lymphnode metastasis in patients with muscleinvasive bladder urothelial carcinoma
6    34    1
Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
8    52    1
RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors

RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors
12    74    0
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms

Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
12    78    0
Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
9    46    1
A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression
11    75    1
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: A case-control study

Metabolic syndrome and the risk of urothelial carcinoma of the bladder: A case-control study
7    72    1
Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma

Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma
16    17    1
TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle
12    1    1
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer
23    28    1
PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma

PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
12    30    1
Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq

Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
11    34    1
Epicure: A European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy

Epicure: A European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
9    40    1
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study

Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study
9    45    1
5α-reductase inhibitors impact prognosis of urothelial carcinoma

5α-reductase inhibitors impact prognosis of urothelial carcinoma
7    35    1
High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
11    40    1
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors
11    45    1
Canonical Notch signalling is inactive in urothelial carcinoma

Canonical Notch signalling is inactive in urothelial carcinoma
13    42    1